Andrographolide exerts anti-respiratory syncytial virus activity by up-regulating heme oxygenase-1 independent of interferon responses in human airway epithelial cells
- 14 March 2023
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (5) , 4261-4272
Abstract
Background Respiratory syncytial virus (RSV) is the leading cause of mortality and morbidity in children under the age of five. Despite this, there is still a lack of safe and effective vaccines and antiviral agents for clinical use. Andrographolide exerts antiviral functions against a variety of viruses, but whether (and how) it exerts antiviral effects on RSV remains unclear. Methods and results In vitro RSV infection models using A549 and 16HBE cell lines were established, and the effects of andrographolide on RSV were analyzed via RSV N gene load and proinflammatory cytokine levels. The RNA transcriptome was sequenced, and data were analyzed by R software. Andrographolide-related target genes were extracted via network pharmacology using online databases. Lentiviral transfection was applied to knockdown the heme oxygenase-1 gene (Hmox1, HO-1). Results showed that andrographolide suppressed RSV replication and attenuated subsequent inflammation. Network pharmacology and RNA sequencing analysis indicated that the hub gene HO-1 may play a pivotal role in the anti-RSV effects of andrographolide. Furthermore, andrographolide exerted antiviral effects against RSV partially by inducing HO-1 but did not activate the antiviral interferon response. Conclusion Our findings demonstrated that andrographolide exerted anti-RSV activity by up-regulating HO-1 expression in human airway epithelial cells, providing novel insights into potential therapeutic targets and drug repurposing in RSV infection.Keywords
All Related Versions
Funding Information
- State Key Laboratory of Control and Simulation of Power System and Generation Equipment (QFSKL2020020)
- the leading talents project of Chongqing (the leading talents project of Chongqing)
This publication has 33 references indexed in Scilit:
- Human heme oxygenase 1 is a potential host cell factor against dengue virus replicationScientific Reports, 2016
- Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon responseFree Radical Biology and Medicine, 2016
- Andrographis paniculata: a critical appraisal of extraction, isolation and quantification of andrographolide and other active constituentsNatural Product Research, 2014
- Andrographolide exerts anti‐hepatitis C virus activity by up‐regulating haeme oxygenase‐1 via the p38 MAPK/Nrf2 pathway in human hepatoma cellsBritish Journal of Pharmacology, 2013
- The Antiasthma Effect of Neonatal BCG Vaccination Does Not Depend on the Th17/Th1 but IL-17/IFN-γ Balance in a BALB/c Mouse Asthma ModelJournal of Clinical Immunology, 2011
- Human Heme Oxygenase-1 Deficiency Presenting With Hemolysis, Nephritis, and AspleniaJournal of Pediatric Hematology/Oncology, 2011
- Purification of human respiratory syncytial virus by ultracentrifugation in iodixanol density gradientJournal of Virological Methods, 2008
- Antiviral Activity and Hepatoprotection by Heme Oxygenase-1 in Hepatitis B Virus InfectionGastroenterology, 2007
- The Heme Oxygenase System: Update 2005Antioxidants & Redox Signaling, 2005
- Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitroBiochemical Journal, 1996